Clinical and Research Institute on Addictions

Expanding UB’s alcoholism research training program

6/28/21

A $1.7 million grant from the NIAAA will allow UB to train pre-doctoral students in addition to postdocs.

3/4/19

The mission of the UB Clinical and Research Institute on Addictions (CRIA) is to advance and disseminate knowledge about the causes, consequences, prevention and treatment of substance use disorders.

Innovative, Interdisciplinary Research

3/4/19

CRIA is UB's hub for bright, passionate scientists working on addiction and addiction-related topics. They work in a culture of scientific and organizational support that nurtures creativity and research success.

Expanding Addiction Education

3/4/19

CRIA offers opportunities for researchers and other professionals to develop their skills and knowledge through our postdoctoral research training program, seminars and conferences.

Clinical Research on Cutting-Edge Treatments

3/4/19

Our Addiction Treatment Services (ATS) is the only treatment program in New York State designed specifically for clinical research and plays a fundamental role in the Institute’s ability to test, apply and monitor innovative treatment strategies.

Resources for Colleagues and the Community

11/13/18

We share knowledge with other researchers, treatment providers, legislators and the public to aid understanding of addiction-related issues through regular news releases, seminars, conferences and our Expert Summaries series.

Powerful opioid treatment program developed at UB goes statewide

7/24/19

BUFFALO, N.Y. — A program developed by University at Buffalo emergency medicine physicians to expedite patient access to comprehensive and effective opioid use disorder treatment is going statewide.

previous next

Learn more about how UB is fighting addiction through research, education and clinical care. Together, we are making progress.

Researcher Spotlight

previous next

Jerrold C. Winter, PhD
1/8/20
Your brain on drugs is topic of UB pharmacologist’s new book for a popular audience
David Dietz, PhD
9/23/19
The Daily Mail reports on research by David Dietz, chair of pharmacology and toxicology in the Jacobs School of Medicine and Biomedical Sciences, that explains why opiate users relapse.
Maria Testa, PhD
5/28/19
Marijuana use episodes among couples who frequently use the drug increase the likelihood of experiencing intimacy events, according to the results of a UB-led study, headed by Maria Testa, PhD.
Haj-Dahmane and Shen
2/8/19
Samir Haj-Dahmane, PhD, and Roh-Yu Shen, PhD, each received five-year, $1.8 million grants from the National Institute on Alcoholism and Alcohol Abuse (NIAAA) to study fetal alcohol spectrum disorders (FASD) and how prenatal alcohol exposure affects the brain.
Panayotis (Peter) Thanos, PhD
2/8/19
As nonprescription use of Ritalin increases among young adults, Panayotis (Peter) Thanos, PhD, warns it could result in long-terms risks to certain areas of the brain.

Fighting Opioid Addiction

previous next

UB Hosts Fulbright Scholars
5/2/19
The University at Buffalo was selected by the U.S. Department of State’s Bureau of Educational and Cultural Affairs (ECA) to host nearly 100 Fulbright Foreign Students from around the world on April 24-28, 2019 at the Jacobs School on UB’s Downtown Campus for a three-day Fulbright Enrichment Seminar titled “Combating Addiction and Addressing the Opioid Crisis.”
Buffalo MATTERS
2/8/19
Joshua Lynch, DO, and emergency medicine physicians in the Jacobs School have developed Buffalo MATTERS to expand emergency room treatment for opioid addiction. He shared its success with Lt. Gov. Kathy Hochul and Erie County Commissioner of Health Gale Burstein, MD.
UB joins the Action Collaborative on Countering the U.S. Opioid Epidemic
5/9/19
Jacobs School of Medicine and Biomedical Sciences at UB and the Clinical Research Institute on Addictions commit to the goals of National Academy of Medicine effort